We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Toxicity of Intraocular Gentamicin

Brice Dille, MD
Arch Ophthalmol. 2007;125(10):1442. doi:10.1001/archopht.125.10.1442-a.
Text Size: A A A
Published online


In the April 2007 issue of the Archives, Soheilian et al1 discussed prophylaxis of acute posttraumatic bacterial endophthalmitis. Although the study seems well designed, I was very surprised that the prophylactic treatment included the intravitreal injection of gentamicin sulfate. Conway and Campochiaro2 (in this same journal) discussed back in 1986 how gentamicin can cause macular infarction in the setting of trauma. Again in the Archives, this time in 1989, Conway et al3 showed in primate retinas that gentamicin is definitely toxic, implying that it should never be used intraocularly. Although Soheilian and colleagues discussed studies in rabbits where gentamicin is not toxic when used in an infusion fluid, as recently as December 2005 Hancock et al4 reiterated the significant toxicity of gentamicin in both rabbit and rat retinas. With a quick literature search, at least 9 journal articles can be found discussing the significant retinal toxicity of intraocular and periocular gentamicin. I understand the need to use an antibiotic effective against gram-negative bacteria for such a trial, but the inclusion of a known toxic compound in this study makes the findings not only useless but in fact dangerous to any physician unaware of the prior research who may try to emulate what is recommended in your pages. Those who do not know history are doomed to repeat it.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...